Researcher
Kleijnen, J.M.P.
Full professor - Personal chair
View graph of relations
- 2019
- PublishedGrimm, S. E., Fayter, D., Ramaekers, B. L. T., Petersohn, S., Riemsma, R., Armstrong, N., ... Joore, M. A. (2019). Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(10), 1195-1207. https://doi.org/10.1007/s40273-019-00792-7
- PublishedLang, S. H., Swift, S. L., White, H., Misso, K., Kleijnen, J., & Quek, R. G. W. (2019). A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer. International Journal of Oncology, 55(3), 597-616. https://doi.org/10.3892/ijo.2019.4842
- Publishedvan den Houten, M. M. L., Hageman, D., Gommans, L. N. M., Kleijnen, J., Scheltinga, M. R. M., & Teijink, J. A. W. (2019). The Effect of Supervised Exercise, Home Based Exercise and Endovascular Revascularisation on Physical Activity in Patients With Intermittent Claudication: A Network Meta-analysis. European Journal of Vascular and Endovascular Surgery, 58(3), 383-392. https://doi.org/10.1016/j.ejvs.2018.12.023
- PublishedThielen, F. W., Bueyuekkaramikli, N. C., Riemsma, R., Fayter, D., Armstrong, N., Wei, C-Y., ... Ramos, I. C. (2019). Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal. Pharmacoeconomics, 37(8), 975-984. https://doi.org/10.1007/s40273-018-0740-4
- PublishedRyder, S., Fox, K., Rane, P., Armstrong, N., Wei, C-Y., Deshpande, S., ... Kleijnen, J. (2019). A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective. Pharmacoeconomics, 37(7), 895-919. https://doi.org/10.1007/s40273-019-00795-4
- PublishedRamaekers, B. L. T., Riemsma, R., Grimm, S., Fayter, D., Deshpande, S., Armstrong, N., ... Joore, M. A. (2019). Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(7), 887-894. https://doi.org/10.1007/s40273-018-0738-y
- Publishedvan Laake-Geelen, C. C. M., Smeets, R. J. E. M., Quadflieg, S. P. A. B., Kleijnen, J., & Verbunt, J. A. (2019). The effect of exercise therapy combined with psychological therapy on physical activity and quality of life in patients with painful diabetic neuropathy: a systematic review. SCANDINAVIAN JOURNAL OF PAIN, 19(3), 433-439. https://doi.org/10.1515/sjpain-2019-0001
- Published
- PublishedBuyukkaramikli, N. C., de Groot, S., Riemsma, R., Fayter, D., Armstrong, N., Portegijs, P., ... Al, M. J. (2019). Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 37(2), 141-153. https://doi.org/10.1007/s40273-018-0708-4
- PublishedLang, S., Armstrong, N., Deshpande, S., Ramaekers, B., Grimm, S., de Kock, S., ... Westwood, M. (2019). Clinically inappropriate post hoc exclusion of study participants from test accuracy calculations: the ROMA score, an example from a recent NICE diagnostic assessment. Annals of Clinical Biochemistry, 56(1), 72-81. https://doi.org/10.1177/0004563218782722